Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Asahi Kasei ( (JP:3407) ) has shared an update.
Asahi Kasei reported fiscal 2025 operating income of ¥231.2 billion, up 9.1% year on year, and net income of ¥158.8 billion, up 17.6%, achieving a record-high operating profit for the second straight year before goodwill amortization. Growth was driven by First Priority businesses, particularly in pharmaceuticals and electronics, as the company continued its business portfolio transformation.
For fiscal 2026, Asahi Kasei forecasts operating income of ¥248.0 billion and net income of ¥160.0 billion, targeting a third consecutive record operating profit with increases expected across all segments. The company plans to lift its annual dividend from ¥42 to ¥44 per share and is executing up to ¥40 billion in share repurchases, while highlighting the resilience of its three-sector model and monitoring supply-chain risks from geopolitical tensions.
The most recent analyst rating on (JP:3407) stock is a Buy with a Yen2100.00 price target. To see the full list of analyst forecasts on Asahi Kasei stock, see the JP:3407 Stock Forecast page.
More about Asahi Kasei
Asahi Kasei is a diversified Japanese manufacturer operating across healthcare, homes, and materials, with key growth businesses in pharmaceuticals, critical care, and electronics. The company focuses on transforming its business portfolio toward higher-value sectors, positioning itself for resilient performance despite an opaque global operating environment.
Average Trading Volume: 5,483,841
Technical Sentiment Signal: Buy
Current Market Cap: Yen2088.5B
For an in-depth examination of 3407 stock, go to TipRanks’ Overview page.